Tenon Medical, Inc. Income Statement
TNON|4 years of annual SEC 10-K data (FY2022-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
Tenon Medical, Inc. reported $3M in revenue and $14M in net loss for FY2025. Revenue has grown at a 173.6% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $3.3M | $2.9M | $691.0K | $160.0K |
| Cost of Revenue | $1.6M | $1.7M | $1.3M | $55.0K |
| Gross Profit | $1.7M | $1.2M | -$641.0K | $105.0K |
| SG&A Expense | $7.8M | $7.0M | $7.4M | $2.7M |
| R&D Expense | $2.6M | $3.2M | $2.8M | $1.7M |
| Operating Income | -$13.8M | -$15.7M | -$18.7M | -$6.5M |
| Interest Expense | - | - | $354.0K | $621.0K |
| Net Income | -$13.7M | -$15.6M | -$18.9M | -$7.0M |
| EPS (Basic) | -$11.26 | -$68.64 | -$23.62 | -$7.81 |
| EPS (Diluted) | -$11.26 | -$68.64 | -$23.62 | -$7.81 |
| Shares Outstanding | 3.1M | 325.0K | 1.1M | 990.0K |
| Gross Margin | 52.2% | 42.4% | -92.8% | 65.6% |
| Operating Margin | -420.1% | -537.1% | -2709.8% | -4038.1% |
| Profit Margin | -417.2% | -532.1% | -2737.6% | -4405.0% |